Clinical Trial Update: RejuvenAir™ System Lobectomy Safety and Histology Study [NA]

View source ↗

Summary

A completed clinical trial assessing the safety and histology of the RejuvenAir System in lobectomy for lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: CSA Medical, Inc. | Conditions: Lung Neoplasms, Airway Obstruction | NA | Status: COMPLETED